Indian Vaccine Market Report and Forecast 2018-2023
Over the years, India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines across the globe. Currently, more than two thirds of the total volume of the vaccines manufactured is exported while the rest is utilised domestically. According to a new report by IMARC titled “Indian Vaccine Market Report and Forecast 2018-2023”, the Indian vaccine market reached a value of around INR 69 Billion in 2017, growing at a CAGR of around 18% during 2010-2017.
The strong growth of the market can be attributed to numerous favourable factors. One of the primary forces that is stimulating the market growth is the increasing investments in research and development (R&D) by government funding agencies like the Department of Biotechnology, the Indian Council of Medical Research, and the Ministry of Health and Family Welfare. The launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases in the country, has also significantly added to the market growth. Moreover, with advancement in technology, the vaccine production capacity along with cold chain storage facilities have also been improved. Besides this, the advent of a number of privately owned firms in India have positively transformed the industry. These firms have been making efforts to bring low cost solutions and are increasingly shifting their focus on innovation so as to increase their revenues. Owing to these factors, India has emerged as a global vaccine manufacturing hub.
The report has segmented the Indian vaccine market on the basis of vaccine type. In 2017, varicella accounted for the maximum share of the total monovalent vaccine market in India whereas oral polio accounted for the biggest share of the combined vaccine market in India.The report has also analysed the competitive landscape and provides the profiles of the key players operating in the market. In 2017, GlaxoSmithKline represented the largest player in the Indian vaccine market. Other major players included Sanofi Aventis, Pfizer, Novartis and Serum Institute of India.
This report provides a deep insight into the Indian vaccine industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, pricing analysis, etc. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine industry in any form.
Key Vaccines Covered in the Report
BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent and Dengue
Focus of the Analysis for Each Vaccine
Vaccine Overview
Historical and Current Market Trends
Market Breakup by Prescriber
Market Breakup by Public and Private Sector
Market Outlook
The strong growth of the market can be attributed to numerous favourable factors. One of the primary forces that is stimulating the market growth is the increasing investments in research and development (R&D) by government funding agencies like the Department of Biotechnology, the Indian Council of Medical Research, and the Ministry of Health and Family Welfare. The launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases in the country, has also significantly added to the market growth. Moreover, with advancement in technology, the vaccine production capacity along with cold chain storage facilities have also been improved. Besides this, the advent of a number of privately owned firms in India have positively transformed the industry. These firms have been making efforts to bring low cost solutions and are increasingly shifting their focus on innovation so as to increase their revenues. Owing to these factors, India has emerged as a global vaccine manufacturing hub.
The report has segmented the Indian vaccine market on the basis of vaccine type. In 2017, varicella accounted for the maximum share of the total monovalent vaccine market in India whereas oral polio accounted for the biggest share of the combined vaccine market in India.The report has also analysed the competitive landscape and provides the profiles of the key players operating in the market. In 2017, GlaxoSmithKline represented the largest player in the Indian vaccine market. Other major players included Sanofi Aventis, Pfizer, Novartis and Serum Institute of India.
This report provides a deep insight into the Indian vaccine industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, pricing analysis, etc. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine industry in any form.
Key Vaccines Covered in the Report
BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent and Dengue
Focus of the Analysis for Each Vaccine
Vaccine Overview
Historical and Current Market Trends
Market Breakup by Prescriber
Market Breakup by Public and Private Sector
Market Outlook
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 INDIAN VACCINE INDUSTRY
5.1 Market Overview
5.2 Market Performance
5.2.1 Volume Trends
5.2.2 Value Trends
5.3 Market Breakup by Segment
5.4 Market Forecast
5.4.1 Volume Trends
5.4.2 Value Trends
6 MARKET ANALYSIS OF VARIOUS MONOVALENT AND COMBINED VACCINES
6.1 BCG Vaccine Market
6.1.1 Vaccine Overview
6.1.2 Market Performance
6.1.3 Market Breakup by Prescriber
6.1.4 Market Breakup by Public and Private Sector
6.1.5 Market Forecast
6.2 HIB Vaccine Market
6.2.1 Vaccine Overview
6.2.2 Market Performance
6.2.3 Market Breakup by Prescriber
6.2.4 Market Breakup by Public and Private Sector
6.2.5 Market Forecast
6.3 Influenza Vaccine Market
6.3.1 Vaccine Overview
6.3.2 Market Performance
6.3.3 Market Breakup by Prescriber
6.3.4 Market Breakup by Public and Private Sector
6.3.5 Market Forecast
6.4 Varicella Vaccine Market
6.4.1 Vaccine Overview
6.4.2 Market Performance
6.4.3 Market Breakup by Prescriber
6.4.4 Market Breakup by Public and Private Sector
6.4.5 Market Forecast
6.5 Typhoid Vaccine Market
6.5.1 Vaccine Overview
6.5.2 Market Performance
6.5.3 Market Breakup by Prescriber
6.5.4 Market Breakup by Public and Private Sector
6.5.5 Market Forecast
6.6 Japanese Encephalitis Vaccine Market
6.6.1 Vaccine Overview
6.6.2 Market Performance
6.6.3 Market Breakup by Prescriber
6.6.4 Market Breakup by Public and Private Sector
6.6.5 Market Forecast
6.7 Measles Vaccine Market
6.7.1 Vaccine Overview
6.7.2 Market Performance
6.7.3 Market Breakup by Prescriber
6.7.4 Market Breakup by Public and Private Sector
6.7.5 Market Forecast
6.8 Tetanus Toxoid Vaccine Market
6.8.1 Vaccine Overview
6.8.2 Market Performance
6.8.3 Market Breakup by Prescriber
6.8.4 Market Breakup by Public and Private Sector
6.8.5 Market Forecast
6.9 Hepatitis A Vaccine Market
6.9.1 Vaccine Overview
6.9.2 Market Performance
6.9.3 Market Breakup by Prescriber
6.9.4 Market Breakup by Public and Private Sector
6.9.5 Market Forecast
6.10 Rubella Vaccine Market
6.10.1 Vaccine Overview
6.10.2 Market Performance
6.10.3 Market Breakup by Prescriber
6.10.4 Market Breakup by Public and Private Sector
6.10.5 Market Forecast
6.11 DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market
6.11.1 Vaccine Overview
6.11.2 Market Performance
6.11.3 Market Breakup by Prescriber
6.11.4 Market Breakup by Public and Private Sector
6.11.5 Market Forecast
6.12 OPV (Oral Polio Vaccine) Vaccine Market
6.12.1 Vaccine Overview
6.12.2 Market Performance
6.12.3 Market Breakup by Prescriber
6.12.4 Market Breakup by Public and Private Sector
6.12.5 Market Forecast
6.13 MMR Vaccine Market
6.13.1 Vaccine Overview
6.13.2 Market Performance
6.13.3 Market Breakup by Prescriber
6.13.4 Market Breakup by Public and Private Sector
6.13.5 Market Forecast
6.14 Rotavirus Vaccine Market
6.14.1 Vaccine Overview
6.14.2 Market Performance
6.14.3 Market Breakup by Prescriber
6.14.4 Market Breakup by Public and Private Sector
6.14.5 Market Forecast
6.15 Hepatitis B Vaccine Market
6.15.1 Vaccine Overview
6.15.2 Market Performance
6.15.3 Market Breakup by Prescriber
6.15.4 Market Breakup by Public and Private Sector
6.15.5 Market Forecast
6.16 Pneumococcal Vaccine Market
6.16.1 Vaccine Overview
6.16.2 Market Performance
6.16.3 Market Breakup by Prescriber
6.16.4 Market Breakup by Public and Private Sector
6.16.5 Market Forecast
6.17 Meningococcal Vaccine Market
6.17.1 Vaccine Overview
6.17.2 Market Performance
6.17.3 Market Breakup by Prescriber
6.17.4 Market Breakup by Public and Private Sector
6.17.5 Market Forecast
6.18 Rabies Vaccine Market
6.18.1 Vaccine Overview
6.18.2 Market Performance
6.18.3 Market Breakup by Prescriber
6.18.4 Market Breakup by Public and Private Sector
6.18.5 Market Forecast
6.19 HPV Vaccine Market
6.19.1 Vaccine Overview
6.19.2 Market Performance
6.19.3 Market Breakup by Prescriber
6.19.4 Market Breakup by Public and Private Sector
6.19.5 Market Forecast
6.20 Hexavalent Vaccines
6.21 Dengue Vaccines
7 SWOT ANALYSIS
7.1 Strengths
7.2 Weaknesses
7.3 Opportunities
7.4 Threats
8 VALUE CHAIN ANALYSIS
8.1 Exploratory Stage
8.2 Preclinical and Clinical Development
8.3 Regulatory Approval
8.4 Manufacturing
8.5 Marketing and Distribution
9 PORTER’S FIVE FORCES ANALYSIS
9.1 Overview
9.2 Bargaining Power of Supplier
9.3 Bargaining Power of Buyers
9.4 Degree of Competition
9.5 Threat of New Entrants
9.6 Threat of Substitutes
10 COMPETITIVE LANDSCAPE
10.1 Competitive Structure
10.2 Market by Key Players
11 PRICING ANALYSIS
12 REGULATORY FRAMEWORK
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline
13.2 Sanofi Aventis
13.3 Serum Institute of India
13.4 Panacea Biotec
13.5 Pfizer
13.6 Novartis
13.7 VHB Lifesciences
13.8 Zydus Cadila
13.9 MSD
13.10 Shantha Biotech
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 INDIAN VACCINE INDUSTRY
5.1 Market Overview
5.2 Market Performance
5.2.1 Volume Trends
5.2.2 Value Trends
5.3 Market Breakup by Segment
5.4 Market Forecast
5.4.1 Volume Trends
5.4.2 Value Trends
6 MARKET ANALYSIS OF VARIOUS MONOVALENT AND COMBINED VACCINES
6.1 BCG Vaccine Market
6.1.1 Vaccine Overview
6.1.2 Market Performance
6.1.3 Market Breakup by Prescriber
6.1.4 Market Breakup by Public and Private Sector
6.1.5 Market Forecast
6.2 HIB Vaccine Market
6.2.1 Vaccine Overview
6.2.2 Market Performance
6.2.3 Market Breakup by Prescriber
6.2.4 Market Breakup by Public and Private Sector
6.2.5 Market Forecast
6.3 Influenza Vaccine Market
6.3.1 Vaccine Overview
6.3.2 Market Performance
6.3.3 Market Breakup by Prescriber
6.3.4 Market Breakup by Public and Private Sector
6.3.5 Market Forecast
6.4 Varicella Vaccine Market
6.4.1 Vaccine Overview
6.4.2 Market Performance
6.4.3 Market Breakup by Prescriber
6.4.4 Market Breakup by Public and Private Sector
6.4.5 Market Forecast
6.5 Typhoid Vaccine Market
6.5.1 Vaccine Overview
6.5.2 Market Performance
6.5.3 Market Breakup by Prescriber
6.5.4 Market Breakup by Public and Private Sector
6.5.5 Market Forecast
6.6 Japanese Encephalitis Vaccine Market
6.6.1 Vaccine Overview
6.6.2 Market Performance
6.6.3 Market Breakup by Prescriber
6.6.4 Market Breakup by Public and Private Sector
6.6.5 Market Forecast
6.7 Measles Vaccine Market
6.7.1 Vaccine Overview
6.7.2 Market Performance
6.7.3 Market Breakup by Prescriber
6.7.4 Market Breakup by Public and Private Sector
6.7.5 Market Forecast
6.8 Tetanus Toxoid Vaccine Market
6.8.1 Vaccine Overview
6.8.2 Market Performance
6.8.3 Market Breakup by Prescriber
6.8.4 Market Breakup by Public and Private Sector
6.8.5 Market Forecast
6.9 Hepatitis A Vaccine Market
6.9.1 Vaccine Overview
6.9.2 Market Performance
6.9.3 Market Breakup by Prescriber
6.9.4 Market Breakup by Public and Private Sector
6.9.5 Market Forecast
6.10 Rubella Vaccine Market
6.10.1 Vaccine Overview
6.10.2 Market Performance
6.10.3 Market Breakup by Prescriber
6.10.4 Market Breakup by Public and Private Sector
6.10.5 Market Forecast
6.11 DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market
6.11.1 Vaccine Overview
6.11.2 Market Performance
6.11.3 Market Breakup by Prescriber
6.11.4 Market Breakup by Public and Private Sector
6.11.5 Market Forecast
6.12 OPV (Oral Polio Vaccine) Vaccine Market
6.12.1 Vaccine Overview
6.12.2 Market Performance
6.12.3 Market Breakup by Prescriber
6.12.4 Market Breakup by Public and Private Sector
6.12.5 Market Forecast
6.13 MMR Vaccine Market
6.13.1 Vaccine Overview
6.13.2 Market Performance
6.13.3 Market Breakup by Prescriber
6.13.4 Market Breakup by Public and Private Sector
6.13.5 Market Forecast
6.14 Rotavirus Vaccine Market
6.14.1 Vaccine Overview
6.14.2 Market Performance
6.14.3 Market Breakup by Prescriber
6.14.4 Market Breakup by Public and Private Sector
6.14.5 Market Forecast
6.15 Hepatitis B Vaccine Market
6.15.1 Vaccine Overview
6.15.2 Market Performance
6.15.3 Market Breakup by Prescriber
6.15.4 Market Breakup by Public and Private Sector
6.15.5 Market Forecast
6.16 Pneumococcal Vaccine Market
6.16.1 Vaccine Overview
6.16.2 Market Performance
6.16.3 Market Breakup by Prescriber
6.16.4 Market Breakup by Public and Private Sector
6.16.5 Market Forecast
6.17 Meningococcal Vaccine Market
6.17.1 Vaccine Overview
6.17.2 Market Performance
6.17.3 Market Breakup by Prescriber
6.17.4 Market Breakup by Public and Private Sector
6.17.5 Market Forecast
6.18 Rabies Vaccine Market
6.18.1 Vaccine Overview
6.18.2 Market Performance
6.18.3 Market Breakup by Prescriber
6.18.4 Market Breakup by Public and Private Sector
6.18.5 Market Forecast
6.19 HPV Vaccine Market
6.19.1 Vaccine Overview
6.19.2 Market Performance
6.19.3 Market Breakup by Prescriber
6.19.4 Market Breakup by Public and Private Sector
6.19.5 Market Forecast
6.20 Hexavalent Vaccines
6.21 Dengue Vaccines
7 SWOT ANALYSIS
7.1 Strengths
7.2 Weaknesses
7.3 Opportunities
7.4 Threats
8 VALUE CHAIN ANALYSIS
8.1 Exploratory Stage
8.2 Preclinical and Clinical Development
8.3 Regulatory Approval
8.4 Manufacturing
8.5 Marketing and Distribution
9 PORTER’S FIVE FORCES ANALYSIS
9.1 Overview
9.2 Bargaining Power of Supplier
9.3 Bargaining Power of Buyers
9.4 Degree of Competition
9.5 Threat of New Entrants
9.6 Threat of Substitutes
10 COMPETITIVE LANDSCAPE
10.1 Competitive Structure
10.2 Market by Key Players
11 PRICING ANALYSIS
12 REGULATORY FRAMEWORK
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline
13.2 Sanofi Aventis
13.3 Serum Institute of India
13.4 Panacea Biotec
13.5 Pfizer
13.6 Novartis
13.7 VHB Lifesciences
13.8 Zydus Cadila
13.9 MSD
13.10 Shantha Biotech
LIST OF FIGURES
Figure 1: Indian Vaccine Market: Vaccine Development and Introduction
Figure 2: Indian Vaccine Market: Major Drivers and Challenges
Figure 3: India: Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 4: India: Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 5: India: Monovalent Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
Figure 6: India: Combined Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
Figure 7: India: Vaccine Market Forecast: Doses Administered (in Million), 2018 - 2023
Figure 8: India: Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 9: India: BCG Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 10: India: BCG Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 11: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 12: India: BCG Vaccine Market: Breakup by Sector (in %), 2017
Figure 13: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 14: India: HIB Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 15: India: HIB Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 16: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 17: India: HIB Vaccine Market: Breakup by Sector (in %), 2017
Figure 18: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 19: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 20: India: Influenza Vaccine Market: Sales Value (in Million INR),
Figure 21: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 22: India: Influenza Vaccine Market: Breakup by Sector (in %), 2017
Figure 23: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 24: India: Varicella Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 25: India: Varicella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 26: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 27: India: Varicella Vaccine Market: Breakup by Sector (in %), 2017
Figure 28: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 29: India: Typhoid Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 30: India: Typhoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 31: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 32: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2017
Figure 33: India: Typhoid Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 34: India: JE Vaccine Market: Doses Administered (in Million), 2010 -2017
Figure 35: India: JE Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 36: India: JE Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 37: India: JE Vaccine Market: Breakup by Sector (in %), 2017
Figure 38: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 39: India: Measles Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 40: India: Measles Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 41: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 42: India: Measles Vaccine Market: Breakup by Sector (in %), 2017
Figure 43: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 44: India: Tetanus Toxoid Vaccine Market: Doses Administered
Figure 45: India: Tetanus Toxoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 46: India: Tetanus Toxoid Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 47: India: Tetanus Toxoid Vaccine Market: Breakup by Sector (in %),2017
Figure 48: India: Tetanus Toxoid Vaccine Market: Sales Value Forecast
Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in ‘000), 2010 - 2017
Figure 50: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 51: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 52: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2017
Figure 53: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 55: India: Rubella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 56: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 57: India: Rubella Vaccine Market: Breakup by Sector (in %), 2017
Figure 58: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 59: India: DPT Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 60: India: DPT Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 61: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 62: India: DPT Vaccine Market: Breakup by Sector (in %), 2017
Figure 63: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 64: India: OPV Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 65: India: OPV Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 66: India: OPV Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 67: India: OPV Vaccine Market: Breakup by Sector (in %), 2017
Figure 68: India: OPV Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 69: India: MMR Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 70: India: MMR Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 71: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 72: India: MMR Vaccine Market: Breakup by Sector (in %), 2017
Figure 73: India: MMR Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 74: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 75: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 1: Indian Vaccine Market: Vaccine Development and Introduction
Figure 2: Indian Vaccine Market: Major Drivers and Challenges
Figure 3: India: Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 4: India: Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 5: India: Monovalent Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
Figure 6: India: Combined Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
Figure 7: India: Vaccine Market Forecast: Doses Administered (in Million), 2018 - 2023
Figure 8: India: Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 9: India: BCG Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 10: India: BCG Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 11: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 12: India: BCG Vaccine Market: Breakup by Sector (in %), 2017
Figure 13: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 14: India: HIB Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 15: India: HIB Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 16: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 17: India: HIB Vaccine Market: Breakup by Sector (in %), 2017
Figure 18: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 19: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 20: India: Influenza Vaccine Market: Sales Value (in Million INR),
Figure 21: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 22: India: Influenza Vaccine Market: Breakup by Sector (in %), 2017
Figure 23: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 24: India: Varicella Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 25: India: Varicella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 26: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 27: India: Varicella Vaccine Market: Breakup by Sector (in %), 2017
Figure 28: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 29: India: Typhoid Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 30: India: Typhoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 31: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 32: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2017
Figure 33: India: Typhoid Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 34: India: JE Vaccine Market: Doses Administered (in Million), 2010 -2017
Figure 35: India: JE Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 36: India: JE Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 37: India: JE Vaccine Market: Breakup by Sector (in %), 2017
Figure 38: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 39: India: Measles Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 40: India: Measles Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 41: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 42: India: Measles Vaccine Market: Breakup by Sector (in %), 2017
Figure 43: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 44: India: Tetanus Toxoid Vaccine Market: Doses Administered
Figure 45: India: Tetanus Toxoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 46: India: Tetanus Toxoid Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 47: India: Tetanus Toxoid Vaccine Market: Breakup by Sector (in %),2017
Figure 48: India: Tetanus Toxoid Vaccine Market: Sales Value Forecast
Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in ‘000), 2010 - 2017
Figure 50: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 51: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 52: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2017
Figure 53: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 55: India: Rubella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 56: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 57: India: Rubella Vaccine Market: Breakup by Sector (in %), 2017
Figure 58: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 59: India: DPT Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 60: India: DPT Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 61: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 62: India: DPT Vaccine Market: Breakup by Sector (in %), 2017
Figure 63: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 64: India: OPV Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 65: India: OPV Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 66: India: OPV Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 67: India: OPV Vaccine Market: Breakup by Sector (in %), 2017
Figure 68: India: OPV Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 69: India: MMR Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 70: India: MMR Vaccine Market: Sales Value (in Million INR), 2010 - 2017
Figure 71: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2017
Figure 72: India: MMR Vaccine Market: Breakup by Sector (in %), 2017
Figure 73: India: MMR Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
Figure 74: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010 - 2017
Figure 75: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010 - 2017
LIST OF TABLES
Table 1: Indian Vaccine Market: Key Industry Highlights, 2017 and 2023
Table 2: India: BCG Vaccine: Overview
Table 3: India: HIB Vaccine: Overview
Table 4: India: Influenza Vaccine: Overview
Table 5: India: Varicella Vaccine: Overview
Table 6: India: Typhoid Vaccine: Overview
Table 7: India: JE Vaccine: Overview
Table 8: India: Measles Vaccine: Overview
Table 9: India: Tetanus Toxoid Vaccine: Overview
Table 10: India: Hepatitis A Vaccine: Overview
Table 11: India: Rubella Vaccine: Overview
Table 12: India: DPT Vaccine: Overview
Table 13: India: OPV Vaccine: Overview
Table 14: India: MMR Vaccine: Overview
Table 15: India: Rotavirus Vaccine: Overview
Table 16: India: Hepatitis B Vaccine: Overview
Table 17: India: Pneumococcal Vaccine: Overview
Table 18: India: Meningococcal Vaccine: Overview
Table 19: India: Rabies Vaccine: Overview
Table 20: India: HPV Vaccine: Overview
Table 21: India: Vaccine Market: Key Components in Drug Delivery
Table 1: Indian Vaccine Market: Key Industry Highlights, 2017 and 2023
Table 2: India: BCG Vaccine: Overview
Table 3: India: HIB Vaccine: Overview
Table 4: India: Influenza Vaccine: Overview
Table 5: India: Varicella Vaccine: Overview
Table 6: India: Typhoid Vaccine: Overview
Table 7: India: JE Vaccine: Overview
Table 8: India: Measles Vaccine: Overview
Table 9: India: Tetanus Toxoid Vaccine: Overview
Table 10: India: Hepatitis A Vaccine: Overview
Table 11: India: Rubella Vaccine: Overview
Table 12: India: DPT Vaccine: Overview
Table 13: India: OPV Vaccine: Overview
Table 14: India: MMR Vaccine: Overview
Table 15: India: Rotavirus Vaccine: Overview
Table 16: India: Hepatitis B Vaccine: Overview
Table 17: India: Pneumococcal Vaccine: Overview
Table 18: India: Meningococcal Vaccine: Overview
Table 19: India: Rabies Vaccine: Overview
Table 20: India: HPV Vaccine: Overview
Table 21: India: Vaccine Market: Key Components in Drug Delivery
